tirzepatide once weekly for the treatment of obesity journal club Once-weekly semaglutide 2.4 mg led to significant decreases in body weight and fat mass over 12 months while preserving lean mass and improved muscle function in adults with obesity. Weight and fat Tirzepatide for type 1 diabetes

Bring recent lab work showing elevated blood glucose, A1C, cholesterol, or triglycerides

Remember that diabetes management is individualised, and finding the right treatment sometimes requires trying different options under medical supervision until the optimal balance of efficacy, tolerability, and safety is achieved

During the initial months of tirzepatide therapy, rapid weight loss occurs as the medication reduces appetite, slows gastric emptying (an effect that may attenuate somewhat over time), and improves insulin sensitivity

Avacopan for the treatment of ANCA-associated vasculitis

A thorough medication review is essential when evaluating new symptoms during Ozempic therapy

When DSIP May Not Be Enough Some sleep problems require intervention beyond what DSIP or any peptide can provide